Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL

ABSTRACT Purpose The 2018 American Urological Association guidelines on the Evaluation and Management of Testosterone Deficiency recommended that 300 ng/dL be used as the threshold for prescribing testosterone replacement therapy (TRT). However, it is not uncommon for men to present with signs and s...

Full description

Bibliographic Details
Main Author: Madhusoodanan,Vinayak (author)
Other Authors: Patel,Premal (author), Lima,Thiago Fernandes Negris (author), Gondokusumo,Jabez (author), Lo,Eric (author), Thirumavalavan,Nannan (author), Lipshultz,Larry I. (author), Ramasamy,Ranjith (author)
Format: article
Language:eng
Published: 2019
Subjects:
Testosterone
Chorionic Gonadotropin
Hypogonadism
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000501008
Country:Brazil
Oai:oai:scielo:S1677-55382019000501008

Internet

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000501008

Similar Items